Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of medical economics"
DOI: 10.1080/13696998.2021.1916749
Abstract: AIMS This study evaluated cost-effectiveness of defibrotide versus best supportive care (BSC) for the treatment of hepatic veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) with multiorgan dysfunction (MOD) post-hematopoietic cell transplantation (HCT) in Spain. MATERIALS AND METHODS…
read more here.
Keywords:
phase;
patients severe;
vod sos;
cost ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2018.1421943
Abstract: ABSTRACT Introduction: Hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is an unpredictable condition associated with endothelial-cell damage due to conditioning for hematopoietic stem-cell transplantation (HSCT) or chemotherapy without HSCT. Mortality in patients with VOD/SOS and multi-organ…
read more here.
Keywords:
vod sos;
hepatic veno;
treatment;
disease sinusoidal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical and Applied Thrombosis/Hemostasis"
DOI: 10.1177/1076029620935202
Abstract: Defibrotide is approved to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) with renal/pulmonary dysfunction following hematopoietic cell transplantation (HCT) in adult and pediatric patients in the United States, and to treat severe hepatic VOD/SOS post-HCT…
read more here.
Keywords:
defibrotide;
vod sos;
intravenous defibrotide;
bleeding events ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.5467.5467
Abstract: Background VOD/SOS is an unpredictable, potentially life-threatening complication of conditioning regimens for HSCT or of chemotherapy without HSCT. VOD/SOS with multi-organ dysfunction (MOD; typically defined as renal and/or pulmonary dysfunction) may be associated with survival…
read more here.
Keywords:
defibrotide;
vod sos;
hsct;
vod ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.7047
Abstract: 7047Background: VOD/SOS is an unpredictable, potentially life-threatening complication of HSCT. VOD/SOS with multi-organ dysfunction (MOD) may be associated with > 80% mortality. DF is approved to ...
read more here.
Keywords:
vod sos;
defibrotide post;
timing initiation;
initiation defibrotide ... See more keywords